Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) EBT Margin (2020 - 2022)

RAPT Therapeutics (RAPT) has disclosed EBT Margin for 3 consecutive years, with 2134.2% as the latest value for Q2 2022.

  • Quarterly EBT Margin fell 28034.0% to 2134.2% in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 10900.68% through Mar 2023, down 871234.0% year-over-year, with the annual reading at 5618.53% for FY2022, 387544.0% down from the prior year.
  • EBT Margin hit 2134.2% in Q2 2022 for RAPT Therapeutics, up from 3241.34% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 938.74% in Q3 2020 to a low of 3241.34% in Q1 2022.
  • Historically, EBT Margin has averaged 1675.12% across 3 years, with a median of 1616.87% in 2020.
  • Biggest five-year swings in EBT Margin: skyrocketed 2850bps in 2021 and later crashed -188995bps in 2022.
  • Year by year, EBT Margin stood at 962.83% in 2020, then plummeted by -109bps to 2009.13% in 2021, then dropped by -6bps to 2134.2% in 2022.
  • Business Quant data shows EBT Margin for RAPT at 2134.2% in Q2 2022, 3241.34% in Q1 2022, and 2009.13% in Q4 2021.